Dementia

Dementia is not a specific disease. It is a descriptive term for a collection of symptoms that can be caused by a number of disorders that affect the brain. People with dementia have significantly impaired intellectual functioning that interferes with normal activities and relationships.

What Causes Dementia?

Dementia occurs due to loss of brain function that occurs with certain diseases. It can affect several brain functions such as memory, thinking, language, planning, behavior and judgement. Dementias are usually progressive and worsen with time. They usually are degenerative and non reversible.

Coconut Oil and Dementia

What is Dementia?

Mixed Dementia Prevention and Treatment

Bright Light Therapy and Dementia

Differences Between Alzheimer's and Dementia

Childhood Dementia Causes

Transcutaneous Electrical Nerve Stimulation for Dementia

Dementia Prevention

Antidepressants and Dementia: Is There a Link?

Mixed Dementia Symptoms and Diagnosis

Aromatherapy for Dementia

See more featured articles »

Dementia Symptoms

What is Mixed Dementia?

Migraines and Dementia

Dementia with Lewy Bodies

Does Depression and Anxiety Increase the Risk of Dementia?

Dementia Diagnosis

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Childhood Dementia Signs and Symptoms

Dementia Treatment

Latest Dementia News and Research

Researchers find alarming rates of CTE in former football players

In a new study from Mass General Brigham, Boston University (BU), and the Concussion & CTE Foundation, researchers found evidence that at least 1-in-4 former NFL players who died between 2016 and 2021 had chronic traumatic encephalopathy (CTE) at the time of their death, a much higher prevalence compared to the general population.

25 Aug 2026

Novel blood-based method diagnoses Alzheimer’s disease with high accuracy

Alzheimer's disease (AD) accounts for 60–80% of global dementia cases, with its core pathological feature being the misfolding and aggregation of β-amyloid (Aβ) proteins in the brain.

25 Aug 2026

Dysfunctional myelin-producing brain cells contribute to age-related cognitive decline

Brain cells that produce the protective coating around nerve fibers can become dysfunctional with age and may actively contribute to cognitive decline, according to new research.

25 Aug 2026

Study reveals high prevalence of chronic traumatic encephalopathy among former NFL players

At minimum, nearly a quarter of all former National Football League (NFL) players who died from 2016 to 2021 had confirmed chronic traumatic encephalopathy (CTE) – a neurodegenerative disease linked to repeated head impacts – at death, finds a study published by The BMJ today.

25 Aug 2026

What decades of wine research can, and cannot, tell us about health

A narrative review found that moderate wine intake has repeatedly been associated with lower all-cause and cardiovascular mortality, with proposed mechanisms involving ethanol and grape-derived polyphenols, but the evidence remains largely observational and cannot establish causation. The authors argue that drinking pattern, beverage type, age, cancer risk, and risk-modeling choices all influence how the J-shaped association should be interpreted and how alcohol guidelines are developed.

25 Aug 2026

The diet-Alzheimer’s connection is more complicated than “eat this, avoid that”

A mini-review finds that dietary patterns may influence Alzheimer’s disease through interconnected pathways involving neuroinflammation, insulin resistance, oxidative stress, blood-brain barrier dysfunction, homocysteine, and the gut-brain axis. The authors argue that genetics, sex, age, physical activity, and socioeconomic context may modify these relationships, supporting more individualized approaches to nutrition research and dementia prevention.

25 Aug 2026

Shared protein pathology redefines treatment for multiple neurodegenerative diseases

On the surface, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and limbic-predominant age-related TDP-43 encephalopathy (LATE) might seem like unrelated diseases.

24 Aug 2026

Older brains' language processing network remains resilient to aging

As people age, many cognitive functions tend to decline. Brain scanning studies have revealed corresponding changes in the function of a brain network that is involved in many of these cognitive functions, including working memory and problem-solving.

24 Aug 2026

Disrupted brain-immune signaling may help drive neurodegeneration

A Cell perspective argues that neurodegeneration can emerge from disrupted communication between neural and immune networks, with peripheral immunity, microglia, and gene-regulatory programs all shaping disease processes. The authors propose that restoring immune homeostasis and recalibrating neuroimmune circuits could create new therapeutic and diagnostic opportunities, while emphasizing that many mechanisms remain unresolved in humans.

24 Aug 2026

Lancet review examines possible amyloid-beta transmission through blood transfusions

A review and opinion piece published in The Lancet and led by UCL (University College London) and UCLH researchers discusses the possibility that blood transfusions may inadvertently transmit harmful brain proteins, and whether additional safety measures are warranted as a precaution whilst further research is conducted to better understand these potential risks.

21 Aug 2026

Microglial differences found in genetic and sporadic frontotemporal dementia patients

A study by the University of Eastern Finland revealed for the first time clear differences in the function and gene expression of microglial cells from patients with genetic and sporadic types of frontotemporal dementia.

20 Aug 2026

Two distinct types of brain tissue work together to support cognition in older adults

Researchers from the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC have found that two distinct types of brain tissue work together to support cognition in older adults, and that the health of the brain's short-range wiring may help soften the cognitive effects of gray matter loss.

20 Aug 2026

Re:Cognition Health launches first dedicated Alzheimer's disease-modifying treatment clinic in Ireland

Re:Cognition Health, the UK's largest independent provider of Alzheimer's disease-modifying treatments, announces the opening of its first Irish clinic in Dublin, marking a major milestone in dementia care for Ireland.

19 Aug 2026

Leisure-time exercise linked to lower dementia risk

For years, scientists have known that regular physical activity can help lower the risk of dementia. But new USC research suggests that it's not only the amount but also the activity's context - for work or for leisure - that makes a difference.

18 Aug 2026

UVA researchers find how postoperative delirium may set the stage for dementia

UVA Health researchers have discovered how a form of delirium that often strikes older patients after surgery may set the stage for dementia – and identified a drug that could reverse the underlying brain changes.

18 Aug 2026

Severe mental illness may accelerate dementia and stroke vulnerability

People living with severe mental illness face a substantially higher risk of dementia throughout adulthood, as well as a significantly elevated risk of stroke in early and middle adulthood, according to a large new study based on health records from Catalonia, Spain.

17 Aug 2026

Global epilepsy burden shifts expose widening healthcare access gaps

Epilepsy remains a major public health challenge, but its burden is changing in ways that reveal health inequalities.

14 Aug 2026

In a famous Blue Zone, daily movement was tied to fewer memory complaints

Older adults in Sardinian Blue Zone communities who took more daily steps, spent less time sedentary, perceived their physical health more positively, and had greater confidence in their memory reported fewer memory complaints. Sleep efficiency was not significantly associated with memory complaints, and the cross-sectional study cannot establish cause and effect.

13 Aug 2026

Later-life estrogen therapy associated with lower risk of developing dementia

Use of hormone therapy later in life was associated with lower risk of developing dementia, according to a study published August 12, 2026, in Neurology, the medical journal of the American Academy of Neurology.

12 Aug 2026

Modern blood thinners slow cognitive decline in Alzheimer's patients

People with both atrial fibrillation and Alzheimer's disease who are treated with modern NOAC blood-thinning medicines may experience a slower rate of cognitive decline.

12 Aug 2026